Larvol Delta - MyMD-Pharmaceuticals-Announces-Positive-Clinical-Data-in-Advance-of-Upcoming-Phase-2-Trial-of-MYMD1-for-Extending-Healthy-Lifespan

isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci

https://www.businesswire.com/news/home/20220208005537/en/MyMD-Pharmaceuticals-Announces-Positive-Clinical-Data-in-Advance-of-Upcoming-Phase-2-Trial-of-MYMD-1-for-Extending-Healthy-Lifespan

Feb 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next